Changes in platelet life span in dogs with mitral valve regurgitation

Journal of Veterinary Internal Medicine

Volumn 16, Issue 4, 2002, Pages 446-451

  Tanaka, Ryou ^a   Murota, Ayako ^a   Nagashima, Yukiko ^a   Yamane, Yoshihisa ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Biotin; Dog; Flow cytometry; Valvular heart disease

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOTINYLATION; BLOOD; CYTOLOGY; DISEASE MODEL; DOG; DOG DISEASE; FEMALE; FLOW CYTOMETRY; MALE; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE;

ANIMALS; BIOTINYLATION; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; FEMALE; FLOW CYTOMETRY; MALE; MITRAL VALVE INSUFFICIENCY;

EID: 0036632405     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2002.tb01263.x     Document Type: Article

References (44)

1. Gavrish AS. Sergienko OV, Ivashchenko TL, Poradun EN. Structural and functional characteristics of platelets in chronic coronary heart disease. Klin Med 1993;71:38-41.
2. McGill DA, Ardlie NG. Abnormal platelet reactivity in men with premature coronary heart disease. Coron Artery Dis 1994;5:889-900.
3. Strano A, Davi G. Platelet function tests and coronary heart disease. Adv Exp Med Biol 1984;164:31-47.
4. Tse HF, Lau CP, Cheng G. Relation between mitral regurgitation and platelet activation J Am Coll Cardiol 1997;30:1813-1818.
5. Walsh PN, Kansu TA, Corbett JJ, et al Platelets, thromboembolism and mitral valve prolapse. Circulation 1981;63:552-559
6. Lin SL, Fisher MJ, Tak T, et al. Platelet activation in patients with mitral valve prolapse. Can J Cardiol 1989;5:84-86.
7. Dumoulin M. Tirmarche M, Horellou MH, et al. Study of platelet diameter distribution in patients with valvular heart disease and with prosthetic heart valve replacement. Haemostasis 1981;10:28-36.
8. Riddle JM, Stein PD, Magilligan DJJ, McElroy HH. Evaluation of platelet reactivity on patients with valvular heart disease. J Am Coll Cardiol 1983;1:1381-1384.
9. Steele P, Weily H, Rainwater J, Vogel R Platelet survival time and thromboembolism in patients with mitral valve prolapse. Circulation 1979;60:43-45.
10. Brodie GN, Firkin BG. Platelet life span in patients with valvular heart disease and Starr-Edwards prostheses. Med J Aust 1972;1: 453-455.
11. Welles EG, Boudreaux MK, Crager CS, Tyler JW. Platelet function and antithorombin plasminogen, and fibrinolytic activities in cats with heart disease. Am J Vet Res 1994;55:619-627.
12. Tanaka R, Yamane Y. Platelet aggregation in dogs with mitral valve regurgitation. Am J Vet Res 2000;61:1248-1251.
13. Shiroshita Y, Tanaka R, Shibazaki A, Yamane Y. Retrospective study of clinical complications occurring after arterial punctures in 111 dogs. Vet Rec 2000;146:16-19.
14. Pesinger RR. Chronic congestive heart failure in dogs - Clinical and pathological findings. Ann N Y Acad Sci 1968,147:330-340.
15. Buchanan JW. Chronic valvular disase (endocardiosis) in dogs. Adv Vet Sci Comp Med 1977;7:75-106.
16. Pirie HM. The pathology of heart disease in the dog. J Small Anim Pract 1967;8:175-183.
17. Luginbuhl H. Detweiler K. Cardiovascular lesions in dogs. Ann N Y Acad Sci 1965;127:517-540
18. Patterson DF, Detweiler DK, Hubben K, Botts RP. Spontaneous abnormal cardiac arrhythmias and conduction disturbances in the dog. Am J Vet Res 1961,22.355-369.
19. Detweiler DK, Hubben K, Patterson DF. Survey of cardiovascular disease in dogs - Preliminary report on the first 1,000 dogs screened Am J Vet Res 1960;21:329-359.
20. Machida N. The pathology of choronic mitral valvular disease (endocariosis) in dogs. J Anim Clin Res Found 1996;5:1-9.
21. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991;69:107-115
22. Sabbah HN, Sharov VG, Lesch M, Goldstein S. Progression of heart failure: A role for interstitial fibrosis. Mol Cell Biochem 1995; 147.29-34.
23. Asano K, Masuda K, Okumura M, et al. Plasma atrial and brain natnuretic peptide levels in dogs with congestive heart failure. J Vet Med Sci 1999;61:523-529.
24. Sisson DD. Ettinger SJ. The physical examination In: Textbook of Canine and Feline Cardiology. Principles and Clinical Practice, 2nd ed. Philadelphia. PA: WB Saunders; 1999:46-64.
25. The COVE Study Group. Controlled clinical evaluation of enalapril in dogs with heart failure: Results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group. J Vet Intern Med 1995;9:243-252.
26. Heilmann E, Friese P. Anderson S, et al Biotinylated platelets: A new approach to the measurement of platelet life span. Br J Haematol 1993;85:729-735.
27. Baker LC, Kameneva MV, Watach MJ, et al. Assessment of bovine platelet life span with biotinylation and flow cytometry. Artif Organs 1998;22:799-803.
28. Dale GL, Wolf RF, Hynes LA, et al. Quantitation of platelet life span in splenectomized dogs Exp Hematol 1996;24:518-523.
29. Dale GL, Friese P, Hynes LA, Burstein SA. Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood 1995;85:1822-1825.
30. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 1995;23.996-1001.
31. Belcher EH, Berlin NI, Eernisse JG, et al. Recommended methods for radioisotope platelet survival studies. By the Panel on Diagnostic Application of Radioisotopes in Hematology, International Committee for Standardization in Hematology. Blood 1977;50.1137-1144.
32. Steele P, Rainwater J, Vogel R. Abnormal platelet survival time in men with myocardial infarction and normal coronary arteriogram Am J Cardiol 1978;41:60.
33. Manning KL, Novinger S, Sullivan PS, McDonald TP. Successful determination of platelet lifespan in C3H mice by in vivo biotinylation. Lab Anim Sci 1996;46:545-548.
34. Peng J, Friese P, Heilmann E, et al. Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood 1994;83:161-166.
35. Gemmell CH, Yen EL, Sefton MV. Flow cytometric analysis of material-induced platelet activation in a canine model: Elevated microparticle levels and reduced platelet life span. J Biomed Mater Res 1997;37:176-181.
36. Maurer HM, McCue CM, Caul J, Still WJS. Impairment in platelet aggregation in congenital heart disease. Blood 1972:40.207-216.
37. O'Brien JR, Etherington MD, Brant J, Watkins J Decreased platelet function in aortic valve stenosis: High shear platelet activation then inactivation. Br Heart J 1995;74:641-644.
38. Bluestein D, Gutierrez C, Londono M, Schoephoerster RT. Vortex shedding in steady flow through a model of an arterial stenosis and its relevance to mural platelet deposition. Ann Biomed Eng 1999; 27:763-773.
39. Kunishima S, Hattori M, Kobayashi S, et al. Activation and destruction of platelets in patients with rheumatic heart disease. Eur Heart J 1994;15:335-338.
40. Cooper HA, Gersh BJ. Treatment of chronic mitral regurgitation. Am Heart J 1998;135:925-936
41. Seki Y, Machida N, Arimura T, et al. Transmural myocardial infarction caused by thromboembolism associated with mitral insufficiency in a dog. J Vet Med Sci 1998;60:741-743.
42. Frojmovic MM. Platelet biorheology: Adhesive interactions in flow. In: Rao HR, ed. Handbook of Platelet Physiology and Pharmacology. Norwell, MA: Kluwer Academic Publishers; 1999:315-341.
43. Mannaioni PF, Bello MGD, Masini E. Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 1997;46:4-18.
44. Takehara K, Igarashi A, Ishibashi Y. Dipyridamole specifically decreases platelet-derived growth factor release from platelets. Thromb Res 1990,12(Suppl):73-79.